Hodgkin Lymphoma

Knowledge is power. Are you facing a new diagnosis, recurrence, living with metastatic disease, or supporting a loved one through their cancer journey? The Cancer Connect Hodgkin Lymphoma Information Center has current, evidence-based information for you. Get the facts about Hodgkin lymphoma prevention, early detection, treatment, and survivorship, and stay up to date with ongoing Hodgkin lymphoma research that could impact your treatment decisions through our daily cancer news.

CancerConnect Hodgkin Lymphoma Community & Discussions

You are not alone—The CancerConnect Hodgkin Lymphoma Community is the leading Social Media Application for Hodgkin Lymphoma patients and caregivers seeking information, inspiration, and support in the wake of a cancer diagnosis. With over 50,000 members the network offers patients and caregivers a thriving community to support the many ongoing needs from diagnosis to survivorship. Login or register here.

HODGKIN LYMPHOMA NEWS TIPS & FEATURES

Progress Reported in New Treatments for People with Lymphoma

December 29th, 2016

Progress Reported in New Treatments for People with Lymphoma

Research and pharmaceutical executives unveil encouraging clinical trial data at the annual meeting of the American Society of Hematology. Twenty-two years ago, Dr. Gary Gordon, […]


Duration of Blood Storage Does Not Affect Outcomes for Patients Requiring Blood Transfusions

December 1st, 2016

Duration of Blood Storage Does Not Affect Outcomes for Patients Requiring Blood Transfusions

The length of time that blood is stored prior to a blood transfusion, within normal ranges, does not appear to affect mortality among patients requiring […]


Pass it On: It's Leukemia and Lymphoma National Awareness Month

September 1st, 2016

Pass it On: It’s Leukemia and Lymphoma National Awareness Month

Leukemia and lymphoma are both hematologic malignancies, meaning that they involve the blood or bone marrow. The American Cancer Society (ACS) estimates that there will […]


Patients Rising: Voices of Value

September 1st, 2016

Patients Rising: Voices of Value

By Terry Wilcox When Jennifer Hinkel was diagnosed with Hodgkin’s lym­phoma in 1998 at the age of 17, her life as she knew it came […]


CAR Therapy Effective in Advanced Lymphoma

June 20th, 2016

CAR Therapy Effective in Advanced Lymphoma

According to results of several presentations at the 2016 annual meeting of the American Society of Clinical Oncology (ASCO), chimeric antigen receptor (CAR) therapies appear […]


Defitelio® Approved for Life-Threatening Complication of Stem Cell Transplant

March 30th, 2016

Defitelio® Approved for Life-Threatening Complication of Stem Cell Transplant

The United States Food and Drug Administration (FDA) has approved Defitelio® (defibrotide sodium) for the treatment of hepatic veno-occlusive disease (VOD) following a stem cell […]


Radiotherapy for Prostate Cancer Increases Risk of Secondary Cancers

March 14th, 2016

Radiotherapy for Prostate Cancer Increases Risk of Secondary Cancers

Patients with prostate cancer considering radiation therapy should now be informed that radiotherapy raises the risk of developing a secondary cancer. Prostate cancer patients who […]


Crafting a Better T Cell for Immunotherapy

February 25th, 2016

Crafting a Better T Cell for Immunotherapy

New technology, not yet tested in humans, aims to reduce patients’ waiting time, increase potency of T-cell therapy T-cell therapy, a form of immunotherapy that […]


Ask the Expert: Blood Cancer Treatment Progress & What’s Next

October 7th, 2015

Ask the Expert: Blood Cancer Treatment Progress & What’s Next

CancerConnect Presents: Ask the Expert: Blood Cancer Treatment Progress & What’s Next   In this informative web chat, Jacqueline Barrientos, MD discusses blood cancer prevalence, evolution […]


ADCETRIS® Provides High-Activity as Initial Therapy in Elderly with Hodgkin’s Lymphoma

October 6th, 2015

ADCETRIS® Provides High-Activity as Initial Therapy in Elderly with Hodgkin’s Lymphoma

The agent, ADCETRIS® (brentuximab vedotin), provides high anti-cancer activity as initial therapy in elderly patients who might not be able to tolerate standard therapy for […]


More News →